Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Malone

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
International Journal of Cancer|September 9, 1992
The study of markers of biological effect in cancer prevention research trialsP Greenwald, K M Witkin, W F Malone, et al.
Journal of the National Cancer Institute|January 19, 1994
Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end pointA Decensi, S Bruno, M Costantini, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Risk biomarkers and current strategies for cancer chemopreventionG J Kelloff, C W Boone, J A Crowell, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
New agents for cancer chemopreventionG J Kelloff, C W Boone, J A Crowell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end pointA Decensi, R Torrisi, S Bruno, et al.
Journal of the National Cancer Institute|November 5, 1999
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancerU Veronesi, G De Palo, E Marubini, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Strategy and planning for chemopreventive drug development: clinical development plans IIG J Kelloff, J A Crowell, E T Hawk, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
International Journal of Cancer|September 9, 1992
The study of markers of biological effect in cancer prevention research trialsP Greenwald, K M Witkin, W F Malone, et al.
Journal of the National Cancer Institute|January 19, 1994
Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end pointA Decensi, S Bruno, M Costantini, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Risk biomarkers and current strategies for cancer chemopreventionG J Kelloff, C W Boone, J A Crowell, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
New agents for cancer chemopreventionG J Kelloff, C W Boone, J A Crowell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 25, 2000
Randomized trial of fenretinide in superficial bladder cancer using DNA flow cytometry as an intermediate end pointA Decensi, R Torrisi, S Bruno, et al.
Journal of the National Cancer Institute|November 5, 1999
Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancerU Veronesi, G De Palo, E Marubini, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1996
Strategy and planning for chemopreventive drug development: clinical development plans IIG J Kelloff, J A Crowell, E T Hawk, et al.
Pageof 6